LUCCAS MEDICAL GROUP

INDEPENDENT RACINE FAMILY PRACTICE CLINIC

Dr. Bruce Luccas

Dr. Sandeep Ramanujam, MD

Dr. Lori Henderson, DNP

 


 

family practice


 

UPCOMING OFFICE CLOSINGS:

Image result for clipart for april calendar   Friday, April 19, 2019 in observance of Good Friday

Image result for clipart for may calendar Thursday, May 16  and Friday May 17, 2019 

PLEASE CONTINUE TO CALL THE OFFICE NUMBER 262-631-8750 AND THE ANSWERING SERVICE WILL DIRECT YOU TO THE ON CALL PHYSICIAN.  THANK YOU FOR YOUR PATIENCE WITH US DURING THIS TIME.

 

MEDICATION RECALL ALERT:

ANYONE ON THE COMBINATION MEDICATION OF LOSARTAN /HCTZ, OR IRBESARTAN PRODUCTS PLEASE CALL YOUR PHARMACY TO SEE IF IT IS PART OF THE RECALL.  THE NON-COMBO MEDICATION IS NOT PART OF THIS RECALL.

 

We have been updated on the specific lot numbers of the combination medications and we have some reporting information for you listed below:

Losartan/HCTZ 50/12.5 mg   Lot Numbers: BP02C008; BEF7D006; 

Losartan/HCTZ 100/12.5 mg Lot Numbers: BX35C020; BX35C049; BX35C023; BX35C022

Irbesartan 300mg Lot Number 331B18009

Irbesartan/HCTZ 300/12.5 mg 30 count bottle   Lot Numbers: 327A18001; 327A18002

Irbesartan/HCTZ 300/12.5 mg 90 count bottle  Lot Numbers:  327B18008;  327B18009

Irbesartan/HCTZ 150/12.5 mg 30 count bottle  Lot Numbers:  325D18004; 324D18005

Irbesartan/HCTZ  150/12/5 mg 90 count bottle  Lot Number:  325B18004

IF YOU HAVE HAD ANY ADVERSE REACTIONS OR QUALITY PROBLEMS WITH THE USE OF THESE PRODUCTS YOU MAY USE THE FOLLOWING FOR REPORTING:

ONLINE:  WWW.FDA.GOV/MEDWATCH/REPORT.HTM

REGULAR MAIL OR FAX:  DOWNLOAD A FORM AT WWW.FDA.GOV/MEDWATCH/GETFORMS.HTM OR CALL 1-800-332-1088 TO REQUEST A REPORTING FORM, THEN COMPLETE AND RETURN TO THE ADDRESS ON THE PRE-ADDRESSED FORMS, OR SUBMIT BY FAX TO 1-800-FDA-0178.

In honor of Dr. Luccas and all our patients who are battling MS, the office participated in the

MUCKFEST CHICAGO on August 25th. 

We had a wonderful group of family, work family, friends and supportive colleagues from Sports Physical Therapists

 

                                                          

On the left is  a picture of the group half way through the course and the right is at the finish line

Please help us fundraise for this worthy cause by donating to our team the LUCCAS MUDDICAL GROUP

Click here to donate

   Many of you have received our office letter detailing our current updates.  There is a copy of it attached click  here  if you did not receive your own copy.

 

  Effective April 1, 2017, In accordance with the Wisconsin Department of Safety and Professional Services, all patients receiving Schedule V prescriptions will have to sign a medication management agreement with our office and will be subject to state electronic prescription tracking.

REMINDER: YOU SHOULD CALL OUR OFFICE FIRST FOR NON LIFE THREATENING ILLNESSES. We will do our best to triage your issues and see you same day.

Our office implemented a new Electronic Medical Record system as of October 2016.  Please have patience with us as we close out our old system and work out the kinks of the new system.  

With this system, we will be able to give you access to your medical chart at our office.

 If we have not received your email information, please contact us at Luccasfax@gmail.com with your email address so we can send you login details.    Thank you

Due to the multitude of requirements to meet the Insurance regulated Quality Reporting Measures, We will be requesting of each patient to fill out a patient packet of forms which cover many of the requirements for the reporting measures.  Thank you for your cooperation.  

 ACCOUNTABLE CARE COALITION

WILL BE REACHING OUT TO MANY OF OUR MEDICARE PATIENTS WITH A QUESTIONNAIRE
Please consider filling this questionnaire out and sending it back as requested.  As a member of the IPN, and to keep our eligibility in many of the medicare health plans, we must be part of an ACO (accountable care organization).  As such, we are subject to evaluations by our ACO which is Accountable Care Coalition.  We thank you for your input.


At the Luccas Medical Group, our mission is to treat our patients with respect in an advanced medical facility, with the utmost quality care. We believe every patient should be treated, as we would like to be treated. Our main concern is the patient - providing the most attentive and compassionate care available.

Our office is a member of the Independent Physician's Network, IPN and Accountable Care Coalition

 

Welcome to Our Office

Our Physicians and our staff offer comprehensive, coordinated, quality care to patients of all ages. We strive for excellence in our services to provide the best medical and preventative treatment available. Based at the campus of Ascension-Wheaten Franciscan All Saints of Racine, we are centrally located for general appointments and urgent care.

Our family practice offers a wide range of services including: Clinical and Diagnostic Laboratory Testing, Total Family Care including Dermatology, Pediatrics, Basic Psychiatric Therapy, minor in-house Surgery and Urgent Care.

BRUCE LUCCAS, MD, LLC

Announcements at Our Practice:

JUAN HAS GRADUATED FROM NURSING SCHOOL AND HE HAS PASSED HIS EXAM AND IS OFFICIALLY A RN!   

CONGRATULATIONS JUAN, WE ARE SO PROUD OF YOU!!!

 

CANCER FACTS AND STATS: BREAST AND CERVICAL CANCER INFORMATION: 

This link will take you to a very useful site for facts and statistics

https://qap.sdsu.edu/index.html

 

Breast cancer screening guidelines from three major organizations are compared in the table below. These guidelines apply to women of average risk only.

Comparison of USPSTF9,10, ACS1,11, and ACOG12 Screening Guidelines
  United States Preventive Services Task Force (USPSTF) 2016 American Cancer Society (ACS) 2015 American Congress of Obstetricians and Gynecologists (ACOG) 2011
Age to begin screening mammography 50
(though women may choose to begin between the ages of 40 and 49)
45
(though women should have the opportunity to begin between ages of 40 and 44)
40
Frequency of screening mammography Biennial Annual
(women 55 and older may transition to biennial or continue with annual mammography)
Annual
Age to end screening mammography 74
(insufficient evidence to assess the balance of benefits and harms of screening mammography in women 75 and older)
Screening mammography should continue for as long as a woman is in good health and has a life expectancy of 10 years or more Women 75 and older should decide whether or not to continue screening mammography in consultation with their healthcare providers
Clinical breast examination (CBE) Insufficient evidence to assess the additional benefits of CBE beyond mammography in women 40 and older Not recommended at any age Should be performed every 1-3 years in women 20-39 years old and annually in women 40 and older
Digital Breast Tomosynthesis (DBT, also called 3D Mammography) Insufficient evidence to assesses benefits and harms of DBT as a primary screening method Too few data on DBT to compare it with 2D mammography N/A

 

Tips from Our Practice

Remember to take your Vitamin D, we recommend a minimum of 2000 IU daily. This should help with the symptoms associated with Vitamin D deficiency.  

April Health Awareness:

  • Alcohol Awareness Month
  • Irritable Bowel Syndrome (IBS) Awareness Month
  • National Autism Awareness Month
  • National Child Abuse Prevention Month
  • National Donate Life Month
  • National Facial Protection Month
  • National Minority Health Month
  • National Sarcoidosis Awareness Month
  • Occupational Therapy Month
  • Oral Cancer Awareness Month
  • Sexual Assault Awareness and Prevention Month
  • Sexual Assault Awareness Month
  • STD Awareness Month
  • Women’s Eye Health and Safety Month

Three different groups have published guidelines for cervical cancer screening: a multidisciplinary partnership among the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology (ACS/ASCCP/ASCP), The United States Preventive Services Task Force (USPSTF), and the American College of Obstetricians and Gynecologists (ACOG). As shown in the table, there is consensus among the groups about nearly all aspects of cervical cancer screening.17-19

Comparison of ACS/ASCCP/ASCP, USPSTF, and ACOG Screening Guidelines

 

 

 

ACS/ASCCP/ASCP

USPSTF

ACOG

 

Recommendations apply to both conventional and liquid-based cytology.

 

When to Start

Age 21

Age 21

Age 21

 

Intervals

Ages 21-29:
Cytology alone every 3 years

Ages 30-65: 
HPV and cytology cotesting every 5 years is preferred

OR

Cytology alone every 3 years is acceptable

Ages 21-29 years:
Cytology alone every 3 years

Ages 30-65: 
HPV and cytology cotesting every 5 years for women who want to extend their screening interval

OR

Cytology alone every 3 years

Ages 21-29:
Cytology alone every 3 years

Ages 30-65: 
HPV and cytology cotesting every 5 years is preferred

OR

Cytology alone every 3 years is acceptable

 

When to Stop

Women older than age 65 following adequate negative prior screening and no history of CIN2 or higher within the last 20 years

Women older than age 65 who have had adequate negative prior screening (as defined below) and who are not otherwise at high risk

(Adequate negative prior screening is defined as 3 consecutive negative cytology results or 2 negative cotests within 10 years before cessation of screening, with the most recent occurring in the past 5 years)

Women older than age 65 with evidence of adequate negative prior screening results and no history of CIN2 or higher

 

Post Total
Hysterectomy

Women who have undergone hysterectomy with removal of the cervix and have no history of CIN2+ should not be screened

Women who have had a total hysterectomy (with removal of the cervix) and no history of a high-grade precancerous lesion (CIN grade 2 or 3) or cervical cancer should not be screened

Women who have had a hysterectomy with removal of the cervix and have never had CIN2 or higher should discontinue routine cytology screening and HPV testing and should not restart for any reason

 

In addition to Pap and cotesting, for women ages 25-65, ACOG, the Society of Gynecologic Oncology (SGO), and ASCCP have stated that FDA-approved primary HPV screening, no more than every 3 years, can be considered as an alternative screening modality if performed per ASCCP and the SGO guidelines.17,19

 

 

Login